Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic

J Gen Intern Med. 2021 Dec;36(12):3918-3921. doi: 10.1007/s11606-021-07144-2. Epub 2021 Sep 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / drug therapy
  • Humans
  • Hydroxychloroquine* / adverse effects
  • Pandemics
  • SARS-CoV-2

Substances

  • Hydroxychloroquine

Supplementary concepts

  • COVID-19 drug treatment